Proteinopathy: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 32: | Line 32: | ||
[[Category:Neurodegenerative disorders]] | [[Category:Neurodegenerative disorders]] | ||
[[Category:Protein folding]] | [[Category:Protein folding]] | ||
<gallery> | |||
File:Proteopathy_Abeta_deposits_in_Alzheimer_disease.jpg|Abeta deposits in Alzheimer's disease | |||
File:Amyloid_Liver_Congo_Red_Bar=100um.jpg|Amyloid deposits in liver stained with Congo Red | |||
File:Immunostaining_(brown)_of_alpha-synuclein_in_Lewy_Bodies_and_Lewy_Neurites_in_the_neocortex_of_a_patient_with_Lewy_Body_Disease.jpg|Alpha-synuclein in Lewy Bodies and Lewy Neurites | |||
File:Tauopathy_in_Alzheimer's_disease.jpg|Tauopathy in Alzheimer's disease | |||
</gallery> | |||
Revision as of 11:27, 18 February 2025
Proteinopathy refers to a broad range of diseases that are caused by proteins that become structurally abnormal, and thereby disrupt the function of cells, tissues and organs of the body. Proteinopathies include Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and Prion diseases.
Overview
Proteinopathies are caused by certain proteins that fail to fold into their normal configuration. In this misfolded state, the proteins can become toxic and can aggregate into insoluble protein aggregates that contribute to the disease process. This is a common mechanism in neurodegenerative diseases, systemic diseases, and many other conditions.
Types of Proteinopathies
There are several types of proteinopathies, which are classified based on the protein involved and the disease it causes. These include:
- Amyloidosis: This is a group of diseases in which abnormal proteins, known as amyloids, build up in tissues and organs.
- Tauopathies: These are a class of neurodegenerative diseases associated with the pathological aggregation of tau protein in the human brain.
- Synucleinopathies: These are neurodegenerative diseases characterized by the abnormal accumulation of aggregates of alpha-synuclein protein in neurons, nerve fibers or glial cells.
Treatment
Treatment for proteinopathies is largely symptomatic, focusing on improving quality of life and slowing disease progression. However, research is ongoing to find treatments that can target the underlying protein misfolding and aggregation.
See Also
References
<references />


